Bromelain is a natural enzyme found in pineapples that researchers are now looking at for managing various health problems. It has shown potential for conditions like cancer, cardiovascular disease, and metabolic disease. However, the current picture is not yet complete. Most of what we know comes from tests in test tubes and on animals. There is very limited evidence from actual human trials. This means we cannot yet say for sure how well it works in people or what the best dose should be. Safety for long-term use also remains unclear. While current data support bromelain as a promising helper in disease management, we need more well-designed studies. These future studies must focus on finding the right amount to take and checking for any long-term risks. Until then, patients should view this as an area of active research rather than a finished solution.
Bromelain shows promise for several diseases but needs more human testing
Photo by Navy Medicine / Unsplash
What this means for you:
Bromelain shows promise but needs more human trials to prove safety and effectiveness. More on Cancer
Narrative review discusses SECTM1 for cancer, cardiovascular disorders, and neurodegenerative diseases without reported outcomes or safety data A narrative review looks at SECTM1 for cancer and other serious conditions
Frontiers · May 23, 2026
Umbrella review associates processed meat consumption with higher risks of cancer and chronic disease outcomes Processed meat links to higher cancer and heart disease risks
Frontiers · Apr 28, 2026
X chromosome inactivation escape and skewing are discussed in a narrative review covering autoimmune, neurodevelopmental, cardiovascular, and cancer conditions X chromosome inactivation escape patterns in female cells
Frontiers · May 29, 2026
Narrative review discusses extracellular vesicles as biomarkers for cancer, neurological disorders, and cardiovascular diseases Extracellular vesicles show promise as biomarkers for multiple diseases
Frontiers · May 19, 2026